Effect of Platelet Additive Solution (PAS) on Random Donor Platelet Concentrates by Bashir, Saira
Journal of Rawalpindi Medical College (JRMC); 2016;20(3):219-221 
 219 
Original Article 
 
Effect of Platelet Additive Solution  (PAS) on Random 
Donor Platelet Concentrates  
  
Saira Bashir 1, Iram Aftab 2, Sadia Akbar 1, Shabbir Hussian 1, Nusrat Bano 2, Shahida Mohsin 1 
1-Department of Haematology, University of Health Sciences, Lahore; 2. Department of Pathology, Jinnah Hospital, Lahore 
 
 
Abstract 
Background: To observe in vitro parameters of 
stored platelets in PAS as compared to plasma for 10 
days. 
Methods: A comparative study was carried out on 
42 samples of random donor platelet concentrates 
(PC). They were divided into two groups of 21 
samples each and stored in incubator at 22°C. In one 
group plasma was replaced with PAS. Sampling was 
done on day 0, 3, 5, 7, 8, 9 and 10. Bacterial cultures 
were carried out. All the samples,which showed 
contamination, were excluded from the study.  
Results: pH and glucose levels were reduced in 
both groups but they dropped more rapidly in PC 
stored in plasma than in PAS (p-value ≤ 0.001). 
However, the difference in LDH levels between two 
groups was not statistically significant. The mean 
values of PO2 were reduced whereas mean values of 
PCO2 were increased in both groups, but these 
changes were seen much less in PC stored in PAS (p-
value ≤ 0.001). The results showed that difference in 
all parameters between two groups was highly 
significant (p-value ≤ 0.001) except LDH. 
Conclusion: All the in vitro parameters were well 
preserved in PC stored in PAS than in plasma. 
 Key Words: Platelet additive solution PAS, PO2, 
PCO2.  
Introduction 
Different types of platelet additive solutions (PAS) are 
used to store platelets. Platelets are usually stored in 
donor plasma at 22- 24°C. However, even under ideal 
conditions, the maximum life span of platelet 
concentrates is 3- 5 days in vitro.1,2  A lot of research 
has been carried out to replace donor plasma with a 
medium which can increase platelets survival and 
functional capability. Such solutions are called platelet 
additive solutions (PAS).3 The PAS includes 
components with specific effects on platelets. Such 
components are not present in plasma or 
anticoagulant.4 The development of PASs started in 
1980s and are being continuously improved.5 A 
number of PAS (PAS- G, T- sol, viacyte, PAS- SSP, 
Plasmalyte- A, PAS- I, PAS- II etc.) have undergone 
experimental evaluations.6 PASs can be prepared by 
addition of different compositions of Na, K, Mg, 
acetate, citrate, gluconate and phosphate.7 The use of 
PAS has several advantages. It reduces transfusion of 
unwanted antibodies and increases more plasma 
available for fractionation.8 In different studies, it has 
been seen that different in vitro parameters of stored 
platelets  like pH, platelet count, PO2 and PCO2 are 
much better in PAS than in donor plasma .9, 10 In these 
studies, the use of PAS enhanced the shelf life of 
stored platelets to 9- 14 days.11 
Materials and Methods 
Forty two platelet concentrate samples of healthy 
individuals fulfilling the donor criteria were prepared, 
which were divided into two groups, one with PAS 
and other without PAS.  Standard protocols were 
followed to assess the in vitro parameters of platelets. 
Whole blood was taken into 450 mL triplet JMS bags 
containing CPD A1 anticoagulant and random donor 
platelet concentrates were prepared within six hours 
of collection. Platelet rich plasma was separated from 
whole blood by light spin centrifugation at 2500 rpm 
for 3 minutes at 20°C, 50- 70 mL of platelet 
concentrates were obtained from single blood bag. In 
21 samples, approximately 35- 50 mL of plasma was 
removed and equal volume of PAS was added  and 
other 21 samples were left with plasma. These samples 
were kept in platelet incubator at 22°C and 3mL 
sample was taken from both groups on day 0, 3, 5, 7, 8, 
9 and 10 (Table 1).The glucose and LDH levels were 
determined by Micro lab 300 at 546 nm and 340 nm, 
respectively.  The biochemical analysis of pH, PO2 and 
PCO2 was performed, using Gas analyzer (Rapid Lab 
Analyzer 348). Bacterial cultures were carried out on 
all the platelet concentrates on day 0, 5 and 
10.Independent t-test was carried out to evaluate the 
in vitro parameters of platelet concentrates with and 
without PAS on day 0, 3, 5, 7, 8, 9 and 10. Analysis of 
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variance (ANOVA) for repeated measures was also 
used to analyze the data. A p-value of ≤ 0.05 was taken 
as statistically significant. 
Table I: Composition  of different  PAS  (mmol/l) 
Chemicals Plasmalyte PAS II PAS 
III 
PAS 
IIIM 
Composol  
Nacl 90 115.5 77.3 69.3 90 
KCl 5 - - 5 5 
MgCl 3  - - 1.5 1.5 
NaCitrate - 10 10.8 10.8 27 
Na acetate 27 30 32.5 32.5 27 
Na 
phosphate 
- - 28.2 28.2 - 
Na 
Gluconate 
23 - - - 23 
Results 
The pH decreased in both groups during storage but 
this reduction was more in platelet concentrates stored 
in plasma (p-value ≤ 0.001) (Figure 1) .The mean 
values of glucose in platelet concentrates stored 
without PAS were notably decreased during 10 days 
storage. The difference between two groups became 
statistically significant on day- 5 (Table- 2).  
Table- 2: Glucose level of platelet concentrates 
with and without PAS (mmol/ L) 
Platelet 
Storage Days Glucose levels 
p 
value 
  Without PAS With PAS   
Day 0( Baseline) 14.8+ 0.7 15.1+ 0.8 0.23 
Day 3 13.9 + 0.7 14.6+ 0.7 0.01 
Day 5 13.1+ .8 14.0+ 0.6 0.01 
Day 7 11.5+ 0.7 13.4+0.7 0.001 
Day 8 10.3+ 0.5 12.4+ 0.9 0.001 
Day 9 9.4+ 0.5 11.3+ 1.1 0.001 
Day 10 8.3+0.3 10.2+ 0.9 0.001 
Results shown as mean + SD of 16 samples without PAS and 
16 samples with PAS by using independent-t- test. 
 
Table-3: LDH level of platelet concentrates with 
and  without PAS (µ/ L) 
Platelet Storage Days LDH level p value 
  Without PAS With PAS   
Day 0 ( Baseline) 140.6+ 6.9 144.0+6.6 0.16 
   Day 3 144.5 + 6.2 148.1 +6.5 0.11 
   Day 5 148.7+ 6.6 152.5+.6.0 0.1 
  Day 7 154.1+8.4 157.1+5.8 0.25 
  Day 8 160.5+9.0 162.5+6.4 0.49 
  Day 9 173,7.1+9.3 175.3+ 7.3 0.58 
  Day 10 172.6+ 10.1 171.9+ 8.1 0.82 
Results shown as mean + S.D of 16 samples without PAS and 16 
samples with PAS by using independent- t-test. 
DH levels increased in both groups during 10 days 
storage but the difference was insignificant (Table- 3). 
The PO2 levels increased in both media but this 
increase was seen more in plasma and the difference 
between two groups was statistically significant 
(Figure-2). PCO2 levels were measured at various 
times and showed a significant decline in PCO2 levels 
in PC without PAS( Figure-3). 
 
 
Figure-1: The pH in platelet concentrates in two groups 
(with and without PAS)s. The difference between two 
groups during 10 days of repeated measurements using 
ANOVA started becoming significant by day 7. 
 
Figure-2:  PO2 in random donor platelet concentrates in 
two groups (with and without PAS)s. The difference 
between two groups of repeated measurements using 
ANOVA started becoming significant by day 7.   
 
Figure-3: The mean values of PCO2 in random donor 
platelet concentrates in two groups (with and without 
PAS) . The difference between two groups of repeated 
measurements using ANOVA was highly significant by 
day 3. 
Discussion 
The present study was done to assess different 
parameters of platelets stored in plasma and PAS like 
pH, glucose, LDH, PO2 and PCO2.Basis for including 
these parameters in this study is that there are two 
pathways through which platelets generate energy. 
One is Tri-carboxylic acid cycle (85%) and other is 
glycolysis (15%).6According to the recommendations 
of American Association of Blood Banks, the pH level 
of > 6.2 is an essential requirement for the quality 
control of blood components.12  In present study pH of 
platelet concentrates stored in PAS was well 
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maintained  till day 10 while the pH of platelets  in 
plasma dropped rapidly after day 5  (p-< 0.001).  
The PAS Plasmalyte- A used in this study contains 
acetate which acts as a buffer.  During storage platelets 
use the anaerobic pathway of glycolysis and oxidative 
pathway of tri-carboxylic acid cycle for energy 
production.Major substrate for TCA pathway is free 
fatty acids(FFA). As PAS containing platelet 
concentrates contains less plasma, only small amount 
of FFA would be available for platelet metabolism. In 
this study the PAS contains acetate which is used as a 
substrate for platelet metabolism.  By the formation of 
bicarbonate from the carbon dioxide produced by the 
acetate, very stable pH levels are maintained during 
platelet storage.13 Our results are consistent with the 
findings of two other groups.14,15 In conflict, studies 
carried out by some other groups showed a rapid fall 
in pH due to the very limited buffering capacity of 
Composol PAS.16  
Glucose levels decreased during storage in both 
groups but this decrease was seen more in plasma (p- 
≤ 0.001).Studies on PAS showed that presence of 
glucose is crucial for platelet metabolism.5,17 LDH 
levels were raised in both groups but the rise was 
slightly more in plasma. The difference between the 
groups was not statistically significant. The buffering 
capacity of other platelet additive solutions 
(Composol) is approximately half to that of plasma, so 
they are more susceptible to the production of LDH by 
the platelets.13 In this study, acetate,present in the 
PAS- Plasmalyte A, was found to be able to reduce 
LDH formation.18,19 The difference in the results of 
various researches probably originated from the 
different constituents of the PAS used. 19 
The oxygen levels rose and carbon dioxide levels 
decreased during storage in both groups but these 
changes were seen early in plasma than in PAS 
indicating that oxygen consumption was reduced 
along with production of carbon dioxide (p- < 0.001). 
In another study, during 12 days storage of platelets in 
plasma and PAS similar results were reported.5 
This study showed that all the parameters of stored 
platelets were well preserved in PAS but real effect of 
PAS on platelets can be uncovered only in human 
body. The platelets can be stored only at room 
temperature and so there is a risk of bacterial 
contamination. Further studies are required to 
overcome these problems. 
Conclusion 
PAS could replace plasma as a storage media for 
platelet concentrates to increase the life span of 
platelets. All the in vitro parameters were well 
preserved in platelet concentrates stored in PAS than 
in plasma. 
 
References 
1. Tulika C, Ashish G, Ashutosh K. Extended shelf life of 
random donor platelets stored for 7 days in platelet additive 
solution at different temperatures. Biomed J 2014; 211-17. 
2. Singh RP, Marwaha N, Malhotra P,Dash S. Quality 
assessment of platelet concentrates prepared by platelet rich 
plasma–platelet concentrates, buffy coat poor–platelet 
concentrates methods. Asian J Transfus Sci 2009; 3: 86- 94. 
3. Mitta K and Kaur R. Platelet storage lesion: An update. Asian 
J Transfus Sci 2015; 9: 1-3. 
4. Gulliksson H. Additive solutions for the storage of platelets 
for transfusion. Transfus Med 2000; 10: 257- 64.  
5. Vandermeer PF, Pietersz RNI and Reesink HW. Storage of 
platelets in additive solution for up to 12 days with  good in 
vitro quality. Transfusion 2004; 44: 1204- 11. 
6. Tynngard N. Preparation, storage and quality control of 
platelet concentrates. Transfus Apher Sci 2009; 41: 97-104. 
7. Van der meer PF.Platelet additive solutions: a future 
perspective.Transfus Clin Biol 2007;14:522-25. 
8. Ringwald J, Zimmermann R and Eckstein R. The new 
generation of platelet additive    solution for storage at 22ºC: 
development and current experience. Transfus Med Rev 
2006; 20: 158-64.  
9. Karnichi K, Johnson C, Ericson D, St Cyr J and Rao  G. 
Platelet storage solution improves the in vitro function of 
preserved platelet concentrate. Vox Sang 2003;85:262-66. 
10. Stiegler G.  Five days storage in apheresis platelet 
concentrates in the new additive solution T-Sol; Changes of 
metabolic markers. Transfus Med Hematol 2002; 29: 18- 
22. 
11. Hornsey VS, Mccol K, Drummond O, McMillan L, Morrison 
L and MacGregor IR.  Extended storage of platelets platelet 
additive solution. Vox Sang 2006; 91: 41- 46. 
12. Das S, Kumar H. The pH estimation in stored platelets: An 
institutional study. IntJTherap appl2015; 27: 8- 
   15. 
13. Gulliksson H. Platelet additive solutions: current status. 
Immunohematology 2007; 23: 14- 19.  
14. Bertolini F, Murphy S, Rebulla P and Sirchia G. Role of 
acetate during platelet storage in a synthetic medium. 
Transfusion 1992; 32: 152- 56.     
15. 15. Sweeney J, Kouttab N, Holme S, Kurtis J, Cheves T. 
Storage of platelet-rich plasma-derived platelet   concentrate 
pools in plasma and additive solution. Transfusion 2006; 46: 
835- 40.  
16. Izadpanahi HA, Yari F, Khorramizadeh MR. Evaluation of 
biochemical parameters of platelet concentrates stored in 
plasma or in a platelet additive solution(Composol). Iran J 
Pediatr Hematol Oncol 2011; 1: 83- 88. 
17. Amorini AM, Tuttobene M, Lazzarino G . Evaluation of 
biochemical   parameters in platelet concentrates stored in 
glucose solution. Blood Transfus 2007; 5: 24- 32. 
18. Gulliksson H, Sandgren P, Sjödin A.Storage of platelets: 
effects associated with high platelet content in platelet 
storage containers. Blood Transfus  2012; 10: 205–12. 
19. Wagner, A Myrup H, Awatefe, Thompson-Montgomery D. 
Maintenance of platelets in vitro properties during 7-day 
storage in M-sol with a 30-hour interruption of agitation. 
Transfusion 2008; 48: 2501-07.  
 
 
 
